Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lucemyra (lofexidine) for the Management of Opioid Withdrawal Symptoms

Drug (Brand / Generic)

Lucemyra™ / lofexidine

Developed by

US WorldMeds

Therapy Class

Non-opioid medication

Product Description

Central alpha 2-adrenergic agonist

Current Indication

Management of Opioid withdrawal symptoms

Development Status

Approved in the US
Expand

Go Top